전기생리학 기기 시장 - 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of electrophysiology devices Market

The global electrophysiology devices market is witnessing steady growth due to the rising prevalence of cardiac rhythm disorders and increasing adoption of advanced interventional cardiology procedures. Electrophysiology devices are widely used for the diagnosis and treatment of heart rhythm abnormalities such as atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. These devices include ablation catheters, diagnostic catheters, mapping systems, and related accessories that help clinicians precisely identify and treat abnormal electrical pathways in the heart.

According to Fortune Business Insights, the global electrophysiology devices market was valued at USD 7.9 billion in 2025. The market is projected to grow from USD 8.76 billion in 2026 to USD 20.1 billion by 2034, exhibiting a CAGR of 10.95% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for 34.48% of the global market share, supported by high disease prevalence and favorable reimbursement policies.

Market Size and Key Metrics

• 2025 Market Size: USD 7.9 billion
• 2026 Market Size: USD 8.76 billion
• 2034 Forecast Market Size: USD 20.1 billion
• CAGR (2026-2034): 10.95%
• Leading Region (2025): North America (34.48% share)

The increasing burden of cardiovascular diseases and growing preference for minimally invasive ablation procedures are key contributors to market expansion.

Impact of COVID-19

The COVID-19 pandemic had a mixed impact on the electrophysiology devices market. While patients with pre-existing heart conditions faced higher risks of myocardial injury, myocarditis, and heart failure, the pandemic also led to a sharp decline in elective cardiac procedures. Studies reported a 40-50% decline in hospital admissions for acute myocardial infarction in the U.S. during early 2020. Similarly, Italy witnessed a 49.4% reduction in hospital admissions for acute myocardial infarction in the first half of 2020. This decline temporarily reduced demand for electrophysiology devices and affected revenues of key market players.

Market Trends

A major trend driving the market is technological advancement in electrophysiology systems, particularly in mapping and ablation technologies. North America witnessed market growth from USD 2.72 billion in 2025 to USD 3.0 billion in 2026, supported by the adoption of advanced mapping and imaging systems. The introduction of sensor-enabled and force-sensing ablation catheters has significantly improved procedural accuracy and clinical outcomes.

Market Drivers

The rising prevalence of cardiac arrhythmias is a key driver of market growth. According to the CDC, atrial fibrillation affects 2.7 to 6.0 million people in the U.S., and its prevalence increases significantly with age. Ventricular tachycardia alone accounts for approximately 300,000 deaths annually in the U.S. Increasing awareness, early diagnosis, and the growing use of catheter-based ablation procedures are driving demand for electrophysiology devices globally.

Market Restraints

Despite strong growth prospects, the market faces challenges such as frequent product recalls and limited reimbursement coverage in certain regions. Recalls related to ablation catheters and associated accessories have raised safety concerns and slowed adoption. Additionally, high procedural costs and inadequate reimbursement in developing countries limit market penetration.

Segmentation Analysis

By Type, the market is segmented into ablation catheters, diagnostic catheters, mapping systems, accessories, and others. The ablation catheters segment is expected to hold a 38.77% share in 2026, driven by increasing use in atrial fibrillation treatment.

By Application, supraventricular tachycardia (SVT) dominated with a 39.23% share in 2026, owing to the high success rate of catheter ablation procedures.

By End User, hospitals and ambulatory surgical centers (ASCs) dominated the market with a 78.48% share in 2026, supported by higher procedure volumes and advanced infrastructure.

Regional Analysis

• North America: Market size reached USD 2.72 billion in 2025, driven by high arrhythmia prevalence and reimbursement support.
• Europe: Growth supported by increasing atrial fibrillation prevalence, particularly in Germany and the U.K.
• Asia Pacific: Expected to grow at a significant CAGR due to expanding healthcare infrastructure and rising disease burden.
• Latin America & Middle East & Africa: Moderate growth due to underpenetration and limited access to advanced EP labs.

Key Industry Players

Leading companies operating in the market include Abbott, Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Stereotaxis, AtriCure, AngioDynamics, and Biotronik. These players focus on product innovation, mergers, and regulatory approvals to strengthen their global presence.

Conclusion

In conclusion, the global electrophysiology devices market is set for strong growth from 2025 to 2034, driven by rising cardiovascular disease prevalence, technological innovation, and increasing adoption of catheter-based ablation procedures. With the market projected to grow from USD 7.9 billion in 2025 to USD 20.1 billion by 2034, electrophysiology devices will remain a cornerstone of advanced cardiac care. Continued innovation, improved reimbursement frameworks, and expanding healthcare infrastructure-especially in emerging markets-will play a critical role in shaping the future of this industry.

Segmentation

By Type

• Ablation Catheters
• Diagnostic Catheters
• Mapping System
• Accessories
• Others

By Application

• Atrial Fibrillation
• Supraventricular Tachycardia (SVT)
• Ventricular Tachycardia
• Others

By End User

• Hospitals & ASCs
• Specialty Clinics & Diagnostic Centers

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. New Product Launches by Key Market Players
• 4.2. Prevalence of Tachycardia by Key Regions/ Key Countries, 2025
• 4.3. Technological Advancements in Electrophysiology Devices
• 4.4. Key industry Developments - Mergers, Acquisitions and Partnerships
• 4.5. Impact of COVID-19 on Electrophysiology Devices Market

5. Global Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Ablation Catheters
  • 5.2.2. Diagnostic Catheters
  • 5.2.3. Mapping System
  • 5.2.4. Accessories
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Atrial Fibrillation
  • 5.3.2. Supraventricular Tachycardia (SVT)
  • 5.3.3. Ventricular Tachycardia
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals & ASC's
  • 5.4.2. Specialty Clinics & Diagnostic Centers
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Type
  • 6.2.1. Ablation Catheters
  • 6.2.2. Diagnostic Catheters
  • 6.2.3. Mapping System
  • 6.2.4. Accessories
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Atrial Fibrillation
  • 6.3.2. Supraventricular Tachycardia (SVT)
  • 6.3.3. Ventricular Tachycardia
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals & ASC's
  • 6.4.2. Specialty Clinics & Diagnostic Centers
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Type
  • 7.2.1. Ablation Catheters
  • 7.2.2. Diagnostic Catheters
  • 7.2.3. Mapping System
  • 7.2.4. Accessories
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Atrial Fibrillation
  • 7.3.2. Supraventricular Tachycardia (SVT)
  • 7.3.3. Ventricular Tachycardia
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals & ASC's
  • 7.4.2. Specialty Clinics & Diagnostic Centers
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Type
  • 8.2.1. Ablation Catheters
  • 8.2.2. Diagnostic Catheters
  • 8.2.3. Mapping System
  • 8.2.4. Accessories
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Atrial Fibrillation
  • 8.3.2. Supraventricular Tachycardia (SVT)
  • 8.3.3. Ventricular Tachycardia
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals & ASC's
  • 8.4.2. Specialty Clinics & Diagnostic Centers
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Type
  • 9.2.1. Ablation Catheters
  • 9.2.2. Diagnostic Catheters
  • 9.2.3. Mapping System
  • 9.2.4. Accessories
  • 9.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Atrial Fibrillation
  • 9.3.2. Supraventricular Tachycardia (SVT)
  • 9.3.3. Ventricular Tachycardia
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals & ASC's
  • 9.4.2. Specialty Clinics & Diagnostic Centers
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Electrophysiology Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Type
  • 10.2.1. Ablation Catheters
  • 10.2.2. Diagnostic Catheters
  • 10.2.3. Mapping System
  • 10.2.4. Accessories
  • 10.2.5. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Atrial Fibrillation
  • 10.3.2. Supraventricular Tachycardia (SVT)
  • 10.3.3. Ventricular Tachycardia
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals & ASC's
  • 10.4.2. Specialty Clinics & Diagnostic Centers
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
  • 11.3.1. Abbott
    • 11.3.1.1. Overview,
    • 11.3.1.2. Products,
    • 11.3.1.3. SWOT Analysis,
    • 11.3.1.4. Recent Developments,
    • 11.3.1.5. Strategies,
    • 11.3.1.6. Financials (based on availability)
  • 11.3.2. Medtronic
    • 11.3.2.1. Overview,
    • 11.3.2.2. Products,
    • 11.3.2.3. SWOT Analysis,
    • 11.3.2.4. Recent Developments,
    • 11.3.2.5. Strategies,
    • 11.3.2.6. Financials (based on availability)
  • 11.3.3. Boston Scientific Corporation
    • 11.3.3.1. Overview,
    • 11.3.3.2. Products,
    • 11.3.3.3. SWOT Analysis,
    • 11.3.3.4. Recent Developments,
    • 11.3.3.5. Strategies,
    • 11.3.3.6. Financials (based on availability)
  • 11.3.4. Johnson & Johnson Services, Inc.
    • 11.3.4.1. Overview,
    • 11.3.4.2. Products,
    • 11.3.4.3. SWOT Analysis,
    • 11.3.4.4. Recent Developments,
    • 11.3.4.5. Strategies,
    • 11.3.4.6. Financials (based on availability)
  • 11.3.5. Stereotaxis, Inc.
    • 11.3.5.1. Overview,
    • 11.3.5.2. Products,
    • 11.3.5.3. SWOT Analysis,
    • 11.3.5.4. Recent Developments,
    • 11.3.5.5. Strategies,
    • 11.3.5.6. Financials (based on availability)
  • 11.3.6. AngioDynamics
    • 11.3.6.1. Overview,
    • 11.3.6.2. Products,
    • 11.3.6.3. SWOT Analysis,
    • 11.3.6.4. Recent Developments,
    • 11.3.6.5. Strategies,
    • 11.3.6.6. Financials (based on availability)
  • 11.3.7. Biotronik, Inc.
    • 11.3.7.1. Overview,
    • 11.3.7.2. Products,
    • 11.3.7.3. SWOT Analysis,
    • 11.3.7.4. Recent Developments,
    • 11.3.7.5. Strategies,
    • 11.3.7.6. Financials (based on availability)
  • 11.3.8. Other Prominent Players
    • 11.3.8.1. Overview,
    • 11.3.8.2. Products,
    • 11.3.8.3. SWOT Analysis,
    • 11.3.8.4. Recent Developments,
    • 11.3.8.5. Strategies,
    • 11.3.8.6. Financials (based on availability)

12. Strategic Recommendations